Rob ter Heine

3.6k total citations
163 papers, 2.2k citations indexed

About

Rob ter Heine is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rob ter Heine has authored 163 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 39 papers in Pulmonary and Respiratory Medicine and 37 papers in Oncology. Recurrent topics in Rob ter Heine's work include HIV/AIDS drug development and treatment (27 papers), Lung Cancer Treatments and Mutations (23 papers) and Antibiotics Pharmacokinetics and Efficacy (19 papers). Rob ter Heine is often cited by papers focused on HIV/AIDS drug development and treatment (27 papers), Lung Cancer Treatments and Mutations (23 papers) and Antibiotics Pharmacokinetics and Efficacy (19 papers). Rob ter Heine collaborates with scholars based in Netherlands, United States and Belgium. Rob ter Heine's co-authors include Jos H. Beijnen, Alwin D. R. Huitema, Hilde Rosing, Jan W. Mulder, Roger J. M. Brüggemann, David M. Burger, E.C.M. van Gorp, Ron J. Keizer, Eric C. M. Van Gorp and M. J. X. Hillebrand and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Rob ter Heine

148 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rob ter Heine Netherlands	26	727	453	404	309	282	163	2.2k
Mario Regazzi Italy	36	869 1.2×	410 0.9×	430 1.1×	631 2.0×	194 0.7×	136	3.6k
Polina German United States	20	905 1.2×	280 0.6×	131 0.3×	425 1.4×	202 0.7×	36	1.9k
Nicolas Widmer Switzerland	30	455 0.6×	600 1.3×	350 0.9×	395 1.3×	365 1.3×	72	3.0k
Bharat Damle United States	24	1.0k 1.4×	305 0.7×	344 0.9×	418 1.4×	161 0.6×	63	1.8k
Julie A. Stone United States	36	1.7k 2.3×	846 1.9×	427 1.1×	735 2.4×	255 0.9×	88	3.3k
Bruno Lacarelle France	35	738 1.0×	1.2k 2.6×	335 0.8×	336 1.1×	290 1.0×	169	3.7k
Hassane Izzedine France	31	1.1k 1.5×	763 1.7×	198 0.5×	735 2.4×	722 2.6×	103	4.1k
Gareth J. Veal United Kingdom	32	391 0.5×	1.0k 2.2×	323 0.8×	310 1.0×	570 2.0×	136	3.7k
Jessica Cusato Italy	27	1.1k 1.5×	222 0.5×	370 0.9×	560 1.8×	48 0.2×	164	2.6k
Walid M. Awni United States	30	416 0.6×	528 1.2×	454 1.1×	425 1.4×	221 0.8×	139	3.0k

Countries citing papers authored by Rob ter Heine

Since Specialization

Citations

This map shows the geographic impact of Rob ter Heine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob ter Heine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob ter Heine more than expected).

Fields of papers citing papers by Rob ter Heine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob ter Heine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob ter Heine. The network helps show where Rob ter Heine may publish in the future.

Co-authorship network of co-authors of Rob ter Heine

This figure shows the co-authorship network connecting the top 25 collaborators of Rob ter Heine. A scholar is included among the top collaborators of Rob ter Heine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob ter Heine. Rob ter Heine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pistorius, Arthur M. A., Rob ter Heine, Tim Frenzel, et al.. (2025). Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients. British Journal of Clinical Pharmacology. 91(9). 2755–2761.

Noort, Vincent van der, et al.. (2024). 1258MO Low dose versus standard dose pembrolizumab for treatment of stage IV stage non-small cell lung carcinoma: Results of the pre-planned interim analysis of the NVALT-30 clinical trial. Annals of Oncology. 35. S806–S806. 6 indexed citations

Moes, Dirk Jan A. R., Jeroen J. M. A. Hendrikx, Henk‐Jan Guchelaar, et al.. (2024). Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan. Targeted Oncology. 19(5). 789–796. 1 indexed citations

Biemans, Vince, Dirk Jan A. R. Moes, Frank Hoentjen, et al.. (2023). Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn’s Disease. Digestive Diseases and Sciences. 68(6). 2647–2657. 10 indexed citations

Raaijmakers, J. A. M., Rob ter Heine, Ruben L. Smeets, et al.. (2023). Development and validation of a bioanalytical assay for the measurement of total and unbound teicoplanin in human serum. Journal of Antimicrobial Chemotherapy. 78(11). 2723–2730. 5 indexed citations

Heine, Rob ter, et al.. (2023). Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation. Journal of Antimicrobial Chemotherapy. 78(5). 1219–1224. 1 indexed citations

Spriet, Isabel, Paul E. Verweij, Jeroen Schouten, et al.. (2023). Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies. Clinical Pharmacokinetics. 62(12). 1701–1711. 9 indexed citations

Wolfs, Tom F.W., Rob ter Heine, Eline W. Muilwijk, et al.. (2023). Pharmacokinetic investigations of isavuconazole in paediatric cancer patients show reduced exposure of isavuconazole after opening capsules for administration via a nasogastric tube. Journal of Antimicrobial Chemotherapy. 78(12). 2886–2889. 3 indexed citations

Wekken, Anthonie J. van der, et al.. (2021). Pharmacokinetically‐guided dosing to improve the efficacy of brigatinib in non‐small cell lung cancer patients. British Journal of Clinical Pharmacology. 88(4). 1930–1934. 2 indexed citations

10.

Donders, Rogier, et al.. (2021). The effect of chemotherapy on the exposure–response relation of abiraterone in metastatic castration‐resistant prostate cancer. British Journal of Clinical Pharmacology. 88(3). 1170–1178. 7 indexed citations

11.

Heijden, Charlotte D.C.C. van der, Rob ter Heine, Emma J. Kooistra, et al.. (2021). Effects of dalteparin on anti‐Xa activities cannot be predicted in critically ill COVID‐19 patients. British Journal of Clinical Pharmacology. 88(6). 2982–2987. 5 indexed citations

12.

Somers, Annemie, Sophie Vanhaesebrouck, Rob ter Heine, et al.. (2021). Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units. International Journal of Clinical Pharmacy. 44(2). 564–569. 4 indexed citations

13.

Wolfs, Tom F.W., et al.. (2021). Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study. Journal of Antimicrobial Chemotherapy. 77(3). 699–703. 7 indexed citations

14.

Heine, Rob ter, Ron J. Keizer, Elise J. Smolders, et al.. (2020). Prospective validation of a model‐informed precision dosing tool for vancomycin in intensive care patients. British Journal of Clinical Pharmacology. 86(12). 2497–2506. 29 indexed citations

15.

Muilwijk, Eline W., Dylan W. de Lange, Jeroen Schouten, et al.. (2020). Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing. Antimicrobial Agents and Chemotherapy. 64(10). 22 indexed citations

16.

Flint, Robert B., Sinno H. P. Simons, Peter Andriessen, et al.. (2020). The bioavailability and maturing clearance of doxapram in preterm infants. Pediatric Research. 89(5). 1268–1277. 8 indexed citations

17.

Wijnsma, Kioa L., Rob ter Heine, Dirk Jan A. R. Moes, et al.. (2019). Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab. Clinical Pharmacokinetics. 58(7). 859–874. 93 indexed citations

18.

Flint, Robert B., Rob ter Heine, Edwin Spaans, et al.. (2018). Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns. European Journal of Clinical Pharmacology. 74(12). 1585–1591. 12 indexed citations

19.

Wasmann, Roeland E., Rob ter Heine, Eric P. van Dongen, et al.. (2018). Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults. Antimicrobial Agents and Chemotherapy. 62(7). 30 indexed citations

20.

Reuver, Philip R. de, André J. A. Bremers, Johannes H.W. de Wilt, et al.. (2018). Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure. British Journal of Clinical Pharmacology. 85(1). 47–58. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact